ライフサイエンスコーパス: chest tube

1 an 30% pneumothorax were treated with an 8-F chest tube.

2 iopsies resulted in pneumothorax requiring a chest tube.

3 1.7 microg) or talc slurry (400 mg/kg) via a chest tube.

4 intubated patients with pneumothorax needed chest tubes.

5 12F chest tube and opioids [n = 29]; or 12F chest tube and NSAIDs [n = 28]).

6 ps (24F chest tube and opioids [n = 28]; 24F chest tube and NSAIDs [n = 29]; 12F chest tube and opioi

7 = 114) were randomized to 1 of 4 groups (24F chest tube and opioids [n = 28]; 24F chest tube and NSAI

8 28]; 24F chest tube and NSAIDs [n = 29]; 12F chest tube and opioids [n = 29]; or 12F chest tube and N

9 ision if biopsy was required) received a 24F chest tube and were randomized to receive opiates (n = 1

10 hemorrhage, P > .999; pneumothorax requiring chest tube and/or admission, P = .417).

11 d-chest resuscitation with opened and closed chest tubes and medical and fluid interventions were ina

12 afely treated with short-term, small-caliber chest tubes and require hospital admission only if they

13 ds for blood vessel cannulation or epidural, chest tube, and initial trocar placement often involve t

14 Abscess drainage, placement of chest tubes, and nephrostomies have increased, but bilia

15 essfully as outpatients, with removal of the chest tube before discharge the day of FNAB.

16 cent of patients had at least one episode of chest tube bleeding (median chest tube blood volume over

17 d with younger age (p = 0.009), but not with chest tube bleeding (p = 0.18), other bleeding requiring

18 rted by extracorporeal membrane oxygenation, chest tube bleeding above 60 mL/kg/d was independently a

19 The number of days with chest tube bleeding greater than 60 mL/kg/d was independ

20 evaluate if interventions to prevent or stop chest tube bleeding influence the clinical outcome.

21 Daily chest tube bleeding, results from hemostatic assays, tra

22 fibrinogen was independently associated with chest tube bleeding, whereas platelet count and hemostat

23 odialysis were independently associated with chest tube bleeding, whereas platelet count, coagulation

24 A significantly higher mean 12-h chest tube blood loss (655 +/- 580 ml vs. 503 +/- 378 ml

25 t one episode of chest tube bleeding (median chest tube blood volume over the entire extracorporeal m

26 pneumothorax (coefficient, -0.02; P = .81), chest tube (coefficient, 0.18; P = .26), perilesional he

27 bypass beta correlated well with duration of chest tube (CT) drainage (r=0.90, n =16), net perioperat

28 number of critical deficiencies remain (eg, chest tubes, diagnostics, and orthopedic and neurosurgic

29 Patients with chest tube drainage >2 weeks had an increased risk of PL

30 left atrial (>13 mm Hg) pressures, prolonged chest tube drainage (>21 days), post-operative ventricul

31 015, received simple aspiration (n = 200) or chest tube drainage (n = 202) as first-line treatment.

32 in the fenestrated group had 55% less total chest tube drainage (P=0.036), 41% shorter total hospita

33 es and studies performed and the duration of chest tube drainage and is associated with less pain and

34 The primary end point was 24-hour chest tube drainage and key secondary end point was tota

35 le aspiration had a higher failure rate than chest tube drainage but was better tolerated with fewer

36 n pleural fluid pH to determine the need for chest tube drainage despite a lack of prospective valida

37 mple aspiration is noninferior to first-line chest tube drainage for lung expansion in patients with

38 n 29% in the aspiration group and 18% in the chest tube drainage group (difference in failure rate, 0

39 Mean 24-hour chest tube drainage in clopidogrel-treated patients was

40 (n = 24), defined as >1000 mL of cumulative chest tube drainage in the first 24 postoperative hours,

41 values (r2 = .71) and cumulative mediastinal chest tube drainage in the first 4 postoperative hours i

42 rative blood loss was 0 to 50 cm3, and total chest tube drainage was 110 to 395 cm3.

43 Within the first 24 h of CABG, the median chest tube drainage was 350 ml (interquartile range [IQR

44 of mechanical ventilation was 1 day; median chest tube drainage was 5.5 days (range, 1 to 35).

45 The total amount of chest tube drainage {830 mL [interquartile range (IQR),

46 decline in hemoglobin from the prior value, chest tube drainage, concurrent transfusion of plasma or

47 of mechanical ventilation, intensive care or chest tube drainage, or adverse events.

48 >/=7 days (odds ratio [OR]=9.2, P=0.02) and chest tube duration >/=10 days (OR=22.7, P=0.009).

49 pitalization >/=7 days; OR=1.24, P=0.007 for chest tube duration >/=10 days) and total pulmonary veno

50 pitalization >/=7 days; OR=1.18, P=0.006 for chest tube duration >/=10 days).

51 nutes (range, 47 to 428 minutes), and median chest tube duration was 3 days (range, 1 to 14 days).

52 es is explored, as well as the management of chest tubes during the COVID-19 pandemic.

53 eumothoraces in patients without preexisting chest tubes; five (6.0%) episodes of bronchial hemorrhag

54 th increased duration of hospitalization and chest tube following Fontan completion.

55 8.5; P < 0.001), requirement for additional chest tubes for pneumothorax (OR = 7.5; P < 0.001), bloo

56 Chest tube gas flow increased with increasing inspirator

57 time, amplitude, and mean airway pressure on chest tube gas flow were determined.

58 cent had at least 1 day of bleeding from the chest tube greater than 100 mL/kg/d.

59 scores were lower among patients in the 12F chest tube group (n = 54) vs the 24F group (n = 56) (mea

60 enced hemorrhage or pneumothorax requiring a chest tube had longer lengths of stay (P < 0.001) and we

61 e biopsy group and led to the placement of a chest tube, hospital admission, or both in 1 patient (0.

62 ion was evaluated by comparing prevalence of chest tubes in pneumothorax false-positive and false-neg

63 comprehensive understanding of the types of chest tubes, indications for their effective use, and ke

64 This review describes the types of chest tubes, indications for use, techniques for placeme

65 The talc group were admitted for chest tube insertion and talc for slurry pleurodesis.

66 accuracy but a high rate of pneumothorax and chest tube insertion compared with endobronchial methods

67 Complications during chest tube insertion occurred more commonly with 12F tub

68 ), with a 9.8% (18 of 183 ablation sessions) chest tube insertion rate.

69 he control group (n = 164) underwent bedside chest tube insertion with local anesthesia followed by a

70 eline-based management (aspiration, standard chest tube insertion, or both).

71 or PEARL, reduced rates of pneumothorax and chest tube insertion.

72 rcutaneous CT-guided lung biopsy, especially chest tube insertion.

73 d less access to fiberoptic bronchoscopy and chest tube insertion.

74 nning of the semester and for intubation and chest tube insertion.

75 ee-choice comparison, pneumothorax requiring chest-tube insertion occurred in association with 13 (1.

76 Prehospital chest tube insertions (214 vs 158) and surgical procedur

77 ions, 457 fiberoptic bronchoscopies, and 295 chest tube insertions.

78 In addition, the future direction of chest tubes is explored, as well as the management of ch

79 ial fibrillation, pancreatitis, vulvar pain, chest tube malfunction and conversion to open splenectom

80 Chest tube management is subjective, but the compilation

81 Smaller chest tubes may be less painful than larger tubes, but e

82 prolonged use of invasive materials such as chest tubes, or resulted in spinal cord or nerve root in

83 The clopidogrel group had higher 24-h mean chest tube output (1,224 ml vs. 840 ml, p = 0.001), and

84 usion dose was independently associated with chest tube output (p < 0.001), other bleeding requiring

85 usion dose was independently associated with chest tube output (p < 0.001), other bleeding requiring

86 carriers, and evaluated the impact of FVL on chest tube output and transfusion by using univariate an

87 There was no significant difference in chest tube output between the plasma and PCC groups.

88 (IF) or extracardiac Fontan (EF), days with chest tube output per day >5, 10, and/or 20 mL. kg(-1).

89 primary outcome was postoperative bleeding (chest tube output) from the initial postsurgical intensi

90 he ReVS+ patients had prolonged LOS, greater chest tube output, and more pleurodesis (P<0.05), and PA

91 d need for transfusion of blood products and chest tube output.

92 Early postoperative chest-tube output, blood-product transfusion requirement

93 and modifications to thoracostomy tubes, or chest tubes, over time, but they continue to be a staple

94 a chest tube vs 81% in those not requiring a chest tube, P = .006) and FEV1/FVC (forced vital capacit

95 noted in 171 of 827 (20.7%) patients, with a chest tube placed in 32 of 827 (3.9%), perilesional hemo

96 the incidence of pneumothorax that required chest tube placement (dependent position, 10 of 210 biop

97 sions along fissures predisposed patients to chest tube placement (P <.05).

98 ch was associated with a higher frequency of chest tube placement for pneumothorax.

99 more group B than group A patients required chest tube placement for treatment of pneumothorax (38%

100 rtality compared with emergent trauma center chest tube placement in trauma patients.

101 This was managed with repeat right-sided chest tube placement on the same day.

102 nostic yield, accuracy, and pneumothorax and chest tube placement rates were compared between the two

103 Once pneumothorax occurred, chest tube placement related to the severity of the pati

104 rax occurred in 20 (27%) of 75 biopsies, but chest tube placement was necessary in only three cases (

105 Chest tube placement was needed in 25 (17.4%) of 144 cas

106 Chest tube placement was required in 2.0% of procedures

107 othorax, a significantly higher frequency of chest tube placement was seen in those with severe obstr

108 agement, including the use of thoracentesis, chest tube placement, fibrinolytic therapy and open thor

109 Thoracostomy, or chest tube placement, is used in a variety of clinical i

110 ostprocedural complications of pneumothorax, chest tube placement, perilesional hemorrhage, and hemop

111 dle biopsy and otherwise would have required chest tube placement, underwent percutaneous aspiration

112 ses of pneumothoraces (two patients required chest tube placement, while 10 were asymptomatic and req

113 It can occur with barotrauma and after chest tube placement.

114 is safe and easy to perform and may obviate chest tube placement.

115 Twelve (70%) patients did not require chest tube placement.

116 ple dependent variables for pneumothorax and chest tube placement.

117 heir pneumothorax, which ultimately required chest tube placement.

118 more likely to be symptomatic, necessitating chest tube placement.

119 neumothorax is common and often necessitates chest tube placement.

120 n, number of needle passes, and frequency of chest tube placement.

121 t CT), with eight (5%) biopsies resulting in chest tube placement.

122 hysema were three times as likely to require chest tube placement.

123 the incidence of pneumothorax that requires chest tube placement.

124 After pneumothorax, chest tube placements were related to the presence of em

125 tilization (PRE 70.4%->POST 21.4%), improved chest tube (PRE 24.3%->POST 54.8%) and urinary catheter

126 DeiT-B had lower chest tube prevalence in false-positive predictions than

127 sy were 21% (42 of 199) and 29% (60 of 208); chest tube rates were 9% (18 of 199) and 13% (27 of 208)

128 iables were correlated with pneumothorax and chest tube rates.

129 Patients with high PIV had longer time to chest tube removal (6.9 vs. 6.7 days, p = 0.049) and lon

130 th a median of 7.5 days from intervention to chest tube removal and 15 days from intervention to disc

131 age at 6 hours, 24 hours, and at the time of chest tube removal in the high-dose adenosine cardiopleg

132 as complicated by a large pneumothorax after chest tube removal on postoperative day 3.

133 Chest tube removal, wound drain removal, and arterial li

134 Results were evaluated 1 and 3 months after chest tube removal.

135 Chest tube-requiring Ptx was significantly associated wi

136 age, compared with talc slurry delivered via chest tube, resulted in no significant difference in the

137 hypoxia, hypotension, assisted respirations, chest tube status, Injury Severity Score, total volume o

138 ), catheter wiring for retention (one case), chest tube suctioning (two cases), and surgical removal

139 erial and venous catheterizations, bilateral chest tube thoracostomies, and tracheostomies were perfo

140 Other treatment included chest tube thoracostomy, sump drainage of proximal esoph

141 Chest tube treatment was required in eight (14%).

142 Median duration of chest tube use was comparable in the IPFT (5 [IQR, 4-8]

143 me in 1 second) (51% in patients requiring a chest tube vs 81% in those not requiring a chest tube, P

144 Placement of 12F chest tubes vs 24F chest tubes was associated with a sta

145 ; 95% CI, -11.7 to -0.2 mm; P = .04) and 12F chest tubes vs 24F chest tubes were associated with high

146 After 2 hours, the chest tube was clamped, and if the lung remained expande

147 Pain while chest tube was in place (0- to 100-mm visual analog scal

148 A chest tube was inserted in 13 of 100 patients (13%) in t

149 st tube was placed, and gas flow through the chest tube was measured with a pneumotachometer during H

150 A chest tube was placed, and gas flow through the chest tu

151 Model performance was not different when a chest tube was present or absent on the radiographs (AUC

152 emained expanded for an additional hour, the chest tube was removed and the patients were discharged

153 The second chest tube was removed on postoperative day 8 without co

154 of six catheters (2.5%); in two patients, a chest tube was required for decompression.

155 occurred in 54 of 121 procedures (44.6%); a chest tube was required in 18 cases (14.9%).

156 Gas flow through the chest tube was significantly higher (p <.001) at 5 Hz (6

157 t alveolar ventilation, gas flow through the chest tube was significantly lower at 15 Hz compared wit

158 Placement of 12F chest tubes vs 24F chest tubes was associated with a statistically signific

159 The total amount of bleeding from chest tube were independently associated with increased

160 -0.2 mm; P = .04) and 12F chest tubes vs 24F chest tubes were associated with higher pleurodesis fail

161 Chest tubes were left in place for at least 72 h.

162 Chest tubes were placed in 14 patients (4%): Six patient

163 his necessitated intercostal drainage with a chest tube, which had been placed elsewhere prior to his

164 rately predict the subsequent insertion of a chest tube with an area under the curve (AUC) of 0.93 (9